<DOC>
	<DOCNO>NCT02246816</DOCNO>
	<brief_summary>MP-101 evaluate study see safe tolerable .</brief_summary>
	<brief_title>A Open Label Extension Study Subjects That Complete Study MP-101-CL-001</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Short Bowel Syndrome</mesh_term>
	<mesh_term>Opium</mesh_term>
	<criteria>Be male female adult , 18 year age old Have SBS inadequately control current antidiarrheal medication ( e.g. , loperamide diphenoxylate ) , include subject ileostomy Must deem completer study protocol MP101CL001 . Males nonpregnant , nonlactating female postmenopausal , naturally surgically sterile , agree use effective contraceptive method throughout course study . Postmenopausal define least 12 month natural spontaneous amenorrhea , least 6 week follow surgical menopause ( bilateral oophorectomy ) Females childbearing potential must agree use 1 follow acceptable birth control method : Surgically sterile ( hysterectomy bilateral oophorectomy ) Surgically sterile ( bilateral tubal ligation surgery least 6 week prior study initiation ) Intrauterine device ( IUD ) place least 3 month Abstinence ( sexual intercourse ) Barrier method ( condom diaphragm ) spermicide least 14 day prior screen study completion Stable hormonal contraceptive least 3 month prior study study completion Vasectomized partner Females childbearing potential must negative serum human chorionic gonadotropin ( hCG ) pregnancy test Visit 1 . Be able understand provide sign informed consent Have history active neurological , endocrine , cardiovascular , pulmonary , hematological , immunologic , psychiatric , metabolic disease consider clinically significant , currently control medication , stable deem Investigator Are currently take antibiotic bacterial overgrowth Have know suspected pregnancy , plan pregnancy , lactation Have plan surgery course study Have condition Investigator believe would interfere ability provide inform consent comply study instruction , might confound interpretation study result put subject undue risk</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Short Bowel Syndrome</keyword>
	<keyword>SBS</keyword>
	<keyword>Chronic Diarrhea</keyword>
	<keyword>Short Bowel</keyword>
	<keyword>Short Gut</keyword>
	<keyword>Short Gut Syndrome</keyword>
	<keyword>Anti-Diarrheal</keyword>
	<keyword>Opium Tincture</keyword>
	<keyword>loperamide</keyword>
	<keyword>diphenoxylate</keyword>
	<keyword>ileostomy</keyword>
	<keyword>tincture opium</keyword>
	<keyword>DTO</keyword>
	<keyword>codeine</keyword>
	<keyword>morphine</keyword>
	<keyword>opiate</keyword>
</DOC>